Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025224 | PMC |
http://dx.doi.org/10.1016/j.aprim.2012.03.005 | DOI Listing |
Sci Rep
January 2025
Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, No. 17 Yongwaizheng Street, Nanchang, 330006, Jiangxi Province, China.
The benefit of adjuvant chemotherapy (CT) for hormone receptor-negative T1a and T1bN0M0 breast cancer remains uncertain. Our study was to explore prognostic value and identify candidates of adjuvant CT for these patients. The data of hormone receptor-negative T1a and T1bN0M0 breast cancer patients were extracted from the Surveillance, Epidemiology, and End Results (SEER) database from 2010 to 2015.
View Article and Find Full Text PDFBr J Gen Pract
January 2025
University of Surrey Faculty of Health and Medical Sciences, School of Health Sciences, Guildford, United Kingdom.
Background Estimated incidence of cancer diagnosis during or shortly after pregnancy is 1 in 1,000 women. Pregnancy can impact symptom appraisal and help-seeking for symptoms subsequently diagnosed as cancer. Little is known about the pathway to cancer diagnosis in pregnancy or delays that women can encounter.
View Article and Find Full Text PDFPLoS One
January 2025
School of Geography, Geology and the Environment, Institute for Environmental Futures, University of Leicester, Leicester, United Kingdom.
Dry evergreen Afromontane forests are severely threatened due to the expansion of agriculture and overgrazing by livestock. The objective of this study was to investigate the composition of woody species, structure, regeneration status and plant communities in Seqela forest, as well as the relationship between plant community types and environmental variables. Systematic sampling was used to collect vegetation and environmental data from 52 (20 m x 20 m) (400 m2) plots.
View Article and Find Full Text PDFJAMA Oncol
January 2025
Department of Surgery, University of California, San Francisco.
Importance: Intratumoral immunotherapy that leverages the biological characteristics of high-risk ductal carcinoma in situ (DCIS) may be able to reduce the extent of surgical treatment and provide an alternative approach to improve patient outcomes.
Objective: To determine if combination intratumoral immunotherapy can activate immune cells to shrink or eliminate high-risk DCIS.
Design, Setting, And Participants: This phase 1 open-label nonrandomized clinical trial at a single academic center tested the safety and efficacy of intratumoral immunotherapy in patients with high-risk DCIS, defined as at least 2 of the following present: younger than 45 years, tumor size greater than 5 cm, high-grade, palpable mass, hormone receptor (HR)-negative, or ERBB2-positive.
PLoS One
January 2025
School of Women's and Children's Health, University of New South Wales, Sydney, Australia.
Background: Antenatal care (ANC) coverage in low- and middle-income countries has increased in the past few decades. However, merely increasing care coverage may not enhance maternal and newborn health unless the recommended service components are also provided. Our aim was to assess the quality of ANC and its associated factors in Ethiopia.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!